查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1439971

經顱磁刺激 (TMS) - 全球市場回顧、競爭格局、市場預測 (2030)

Transcranial Magnetic Stimulator - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按訂單生產 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

全球經顱磁刺激 (TMS) 市場規模將於 2023 年達到 11.3461 億美元，到 2030 年將達到 191705 萬美元，預計 2024-2030 年複合年增長率為 9.19%。 經顱磁刺激（TMS）的需求主要是由於阿茲海默症、帕金森氏症等各種神經系統疾病患者數量的不斷增加，以及雙相情感障礙、強迫症等精神疾病合併症病例的迅速增加等。在意識提高、吸煙者數量增加、對非侵入性治療的日益偏好以及產品開發技術創新的推動下，這些是 2024-2030 年預測期內經顱磁刺激 (TMS) 增長的關鍵驅動力。到整體市場的成長。

經顱磁刺激 (TMS) 市場動態

憂鬱症、強迫症等精神疾病的持續增加正在推動經顱磁刺激（TMS）市場的成長。 根據世界衛生組織 (WHO) 2022 年發佈的數據，2019 年全球約有 9.7 億人（即八分之一的人）患有精神障礙。 文件進一步指出，焦慮症和憂鬱症是2019年全球最常見的精神障礙，影響3.01億人，其中包括5,800萬名兒童和青少年。

根據上述數據，2019年，約有2.8億人（其中包括2,300萬名兒童和青少年）患有憂鬱症，佔世界人口的3.8%。

上述文件進一步指出，2019年，全球有4000萬人患有雙相情感障礙，2019年，包括兒童和青少年在內的4000萬人患有反社會行為障礙。

多種神經系統疾病的盛行率正在增加，這可能會對經顱磁刺激 (TMS) 市場產生正面影響。 根據世界衛生組織 (2022) 的數據，2019 年全球約有 850 萬人受到帕金森氏症 (PD) 的影響，根據同一來源，帕金森氏症與 580 萬殘疾調整生命年相關。 患有帕金森氏症和阿茲海默症等神經系統疾病的患者可以從 TMS 治療中受益。

然而，與 TMS 療法相關的副作用以及其他替代刺激療法的存在可能會抑制經顱磁刺激 (TMS) 市場的成長。

經顱磁刺激（TMS）市場區隔分析

按經顱磁刺激 (TMS) 市場的類型細分，深部經顱磁刺激 (dTMS) 類別預計將在 2023 年獲得可觀的收入佔有率。 這可能是由於深部經顱磁刺激（dTMS）的好處和應用與神經精神疾病的有效治療有關。

透過刺激大腦更深更廣的區域，深度TMS以非侵入性和創新的方式為許多心理健康狀況包括腦震盪、創傷後壓力症候群、憂鬱、強迫症、焦慮、成癮等提供有效的治療。

透過直接激活 H 線圈，dTMS 允許磁脈衝瞄準大腦的特定區域，而無需顯著增加磁場強度，從而最大限度地減少治療的副作用和負面影響。

在嘗試各種治療後症狀沒有改善的 MDD 患者可能會透過深度 TMS 得到緩解，與抗憂鬱藥物相比，其風險更小，結果更好。

使用深度 TMS 可以消除與使用抗憂鬱藥物相關的副作用，例如噁心、體重增加、不孕症、嗜睡、慢性腹瀉、口乾、皮疹和記憶喪失。

因此，由於上述因素，預計深部經顱磁刺激 (dTMS) 類別將顯著成長，從而推動整個經顱磁刺激 (TMS) 市場在預測期內的成長。

預計北美將主導整個經顱磁刺激 (TMS) 市場。

在所有地區中，預計到 2023 年，北美將佔據經顱磁刺激 (TMS) 市場的最大佔有率。 由於神經系統疾病盛行率不斷上升、精神疾病患者數量不斷增加、可支配收入高、醫療保健基礎設施完善、大公司的存在、產品開發活動不斷增加以及其他顯著的增長因素，經顱磁刺激（TMS）市場預計見證該地區在 2022-2028 年預測期內的繁榮。

本報告提供了全球經顱磁刺激 (TMS) 市場的研究和分析，包括市場規模和預測、驅動因素和挑戰以及公司和產品概況。

目錄

第一章經顱磁刺激 (TMS) 市場報告簡介

第 2 章經顱磁刺激 (TMS) 市場執行摘要

  • 調查範圍
  • 市場概覽
  • 競爭評估

第三章監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第四章經顱磁刺激（TMS）市場主要因素分析

  • 經顱磁刺激 (TMS) 市場驅動因素
  • 經顱磁刺激 (TMS) 市場的限制與挑戰
  • 經顱磁刺激 (TMS) 市場機會

第五章波特對經顱磁刺激 (TMS) 市場的五力分析

第六章經顱磁刺激（TMS）市場佈局

  • 依類型
    • 深部經顱磁刺激 (dTMS)
    • 重複經顱磁刺激 (rTMS)
    • 其他
  • 依用途
    • 阿茲海默症
    • 強迫症 (OCD)
    • 雙極性憂鬱症
  • 依年齡段
    • 成人
    • 兒童
  • 地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他領域

第 7 章經顱磁刺激 (TMS) 市場公司與產品概況

  • BrainsWay
  • Nexstim
  • Magstim
  • Neuronetics
  • Salience
  • MagVenture, Inc.
  • Axilum Robotics
  • Brainbox Ltd.
  • EB Neuro S.p.A.
  • eNeura Inc.
  • Neurosoft
  • MAG & More GmbH
  • Soterix Medical Inc.
  • Magnus Medical
  • NEUROPREX INC.

第8章KOL瀏覽量

第 9 章專案方法

第10章DelveInsight服務內容

第 11 章關於 DelveInsight

第 12 章免責聲明與聯絡我們

Product Code: DIMDCL0652

Transcranial Magnetic Stimulation (TMS) Market By Type (Deep Transcranial Magnetic Stimulator (DTMS), Repetitive Transcranial Magnetic Stimulator (RTMS), And Others), Application (Alzheimer's Disease, Obsessive Compulsive Disorder (OCD), Bipolar Depression, And Others), Age Group (Adults And Children), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing cases of depression and rising prevalence of neurological diseases

The global transcranial magnetic stimulation (TMS) market was valued at USD 1,134.61 million in 2023, growing at a CAGR of 9.19% during the forecast period from 2024 to 2030 to reach USD 1,917.05 million by 2030. The demand for transcranial magnetic stimulation (TMS) is primarily being boosted by the increasing patient population suffering from various neurological diseases such as Alzheimer's Disease and Parkinson's disease among others, as the surge in cases of psychiatric comorbidities such as bipolar disorder, obsessive-compulsive disorder, and others, rising awareness regarding mental health, rise in many smokers, growing preference for non-invasive treatment methods, and innovation in product development among others, thereby contributing to the overall growth of the transcranial magnetic stimulation (TMS) market during the forecast period from 2024-2030.

Transcranial Magnetic Stimulation (TMS) Market Dynamics:

The continuous rise in cases of psychiatric comorbidities such as depression, obsessive-compulsive disorder, and others is driving the growth of the transcranial magnetic stimulation (TMS) market. As per the data published by World Health Organization (WHO) in 2022, worldwide around 970 million people which makes 1 in every 8 people were living with a mental disorder in 2019. The source further stated that anxiety and depressive disorders with anxiety affecting 301 million people including 58 million children and adolescents were the most common mental disorders in 2019 globally.

As per the above-mentioned source worldwide around 280 million people making up 3.8% of the global population including 23 million children and adolescents were suffering from depression in 2019.

The source mentioned above further stated that worldwide 40 million people experienced bipolar disorder in 2019 and 40 million people, including children and adolescents, were living with conduct-dissocial disorder in 2019.

The prevalence of several neurological disorders is on the rise which can have a positive impact on the transcranial magnetic stimulation (TMS) market. According to WHO 2022, worldwide around 8.5 million people had Parkinson's disease (PD) in 2019 and as per the same source, PD lead to 5.8 million disability-adjusted life years. Patients suffering from neurological disorders such as Parkinson's, Alzheimer's disease, and others can get benefit from TMS therapy.

However, side effects associated with TMS therapy and the presence of other alternative stimulation therapies may restrict the growth of the transcranial magnetic stimulation (TMS) market.

Transcranial Magnetic Stimulation (TMS) Market Segment Analysis:

Transcranial Magnetic Stimulation (TMS) Market by Type (Deep Transcranial Magnetic Stimulator (dTMS), Repetitive Transcranial Magnetic Stimulator (rTMS), and Others), Application (Alzheimer's Disease, Obsessive Compulsive Disorder (OCD), Bipolar Depression, and Others), Age Group (Adults and Children), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the type segment of the transcranial magnetic stimulation (TMS) market, the deep transcranial magnetic stimulator (dTMS) category is expected to amass a significant revenue share in the year 2023. This can be ascribed to the advantages and applications associated with deep transcranial magnetic stimulator (dTMS) effective treatment of neuropsychiatric disorders.

By stimulating the deeper, wider regions of the brain, Deep TMS offers non-invasive, innovative, and effective treatment for numerous mental health conditions including concussions, PTSD, depression, OCD, anxiety, addiction, and more.

The direct activation of H-coils in dTMS enables the magnetic pulses to target specific brain regions without significantly increasing the strength of the magnetic field which helps minimize side effects and negative consequences of the treatment.

Patients with MDD whose symptoms have not improved despite trying various treatments may get relief from deep TMS which offers risk-free and favorable results over antidepressants.

The side effects such as nausea, weight gain, infertility, drowsiness, chronic diarrhea, dry mouth, rash, or memory loss associated with the use of antidepressant drugs are eliminated with the utilization of deep TMS.

Therefore, owing to the above-mentioned factors, the deep transcranial magnetic stimulator (dTMS) category is expected to register significant growth, thereby driving the growth of the overall transcranial magnetic stimulation (TMS) market during the forecast period.

North America is expected to dominate the overall Transcranial Magnetic Stimulation (TMS) Market:

Among all the regions, North America is estimated to account for the largest share of the transcranial magnetic stimulation (TMS) market in the year 2023. Owing to the significance of key growth factors such as the rising prevalence of neurological disorders, increasing cases of psychiatric disorders, high disposable income, sophisticated healthcare infrastructure, presence of key players, increasing product development activities, and others, the market for transcranial magnetic stimulation (TMS) is expected to witness prosperity in the region during the forecast period 2022-2028.

According to the National Institute of Mental Health (NIMH) 2022, about 52.9 million people which stands for 21% of the population experienced mental illness in 2020 in the United States. As per the same source 14.2 million people experienced serious mental illness in the United States in 2020.

The above-mentioned source further stated that around 21.0 million adults had at least one major depressive episode in 2020 in the United States.

Another factor contributing to the growth of the TMS market is the continued rise in the number of individuals involved in smoking. For instance, as per the Centers for Disease Control and Prevention 2022, approximately 40 million people smoke cigarettes in the US. As per the same source, every day nearly 1,600 US youth aged 18 years or younger smoke their first cigarette.

Coupled with the factors mentioned above, the increasing interest of product manufacturers in the region also helps in boosting regional product demand. For instance, in August 2020, BrainsWay Ltd., a global leader in the advanced non-invasive treatment of brain disorders, announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for the Company's deep transcranial magnetic stimulation (Deep TMS) system for its use as an aid in short-term smoking cessation in adults.

Such measures help in gaining the market share for the manufacturers as well as benefit end users in terms of better product pricing from the competition standpoint, thereby driving the North America transcranial magnetic stimulation (TMS) market forward during the forecast period.

Transcranial Magnetic Stimulation (TMS) Market Key Players:

Some of the key market players operating in the transcranial magnetic stimulation (TMS) market include BrainsWay, Nexstim, Magstim, Neuronetics, Salience, MagVenture, Inc., Axilum Robotics, Brainbox Ltd., EB Neuro S.p.A., eNeura Inc., Neurosoft, MAG & More GmbH, Soterix Medical Inc., Magnus Medical, NEUROPREX INC., and others.

Recent Developmental Activities in the Transcranial Magnetic Stimulation (TMS) Market:

In January 2023, Magstim, a global leader in neuroscience research and transcranial magnetic stimulation (TMS) solutions for mental health, announced that it has received US FDA clearance for its Horizon 3.0 (with or without StimGuide+) and E-z Cool Coil to treat adult patients diagnosed with obsessive compulsive disorder (OCD) as well as major depressive disorder (MDD).

In March 2020, Neuronetics, Inc., a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, announced that the US Food and Drug Administration (FDA) has recently granted Breakthrough Device Designation for the Company's NeuroStar Advanced Therapy System for the treatment of bipolar depression.

Key Takeaways from the Transcranial Magnetic Stimulation (TMS) Market Report Study

Market size analysis for current transcranial magnetic stimulation (TMS) market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the transcranial magnetic stimulation (TMS) market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global transcranial magnetic stimulation (TMS) market.

Various opportunities available for the other competitor in the transcranial magnetic stimulation (TMS) market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current transcranial magnetic stimulation (TMS) market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for transcranial magnetic stimulation (TMS) market growth in the coming future?

Target Audience who can be benefited from this Transcranial Magnetic Stimulation (TMS) Market Report Study

Transcranial Magnetic Stimulation (TMS) products providers

Research organizations and consulting companies

Transcranial Magnetic Stimulation (TMS) -related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in transcranial magnetic stimulation (TMS)

Various End-users who want to know more about the transcranial magnetic stimulation (TMS) market and the latest technological developments in the transcranial magnetic stimulation (TMS) market.

Frequently Asked Questions for the Transcranial Magnetic Stimulation (TMS) Market:

1. What is meant by transcranial magnetic stimulation (TMS)?

Transcranial magnetic stimulation (TMS) which involves the application of powerful magnetic fields to particular areas of the brain is safe, non-invasive, and powerful technique indicated for the treatment of various psychiatric and neurological disorders.

2. What is the market for global transcranial magnetic stimulation (TMS)?

The global transcranial magnetic stimulation (TMS) market was valued at USD 1,134.61 million in 2023, growing at a CAGR of 9.19% during the forecast period from 2024 to 2030 to reach USD 1,917.05 million by 2030.

3. What are the drivers for the global transcranial magnetic stimulation (TMS) market?

The demand for transcranial magnetic stimulation (TMS) is primarily being boosted by the increasing patient population suffering from various neurological diseases such as Alzheimer's Disease and Parkinson's disease among others, as the surge in cases of psychiatric comorbidities such as bipolar disorder, obsessive-compulsive disorder, and others, rising awareness regarding mental health, rise in several smokers, and others, thereby contributing to the overall growth of the transcranial magnetic stimulation (TMS) market during the forecast period from 2024-2030.

4. Who are the key players operating in the global Transcranial Magnetic Stimulation (TMS) market?

Some of the key market players operating in the transcranial magnetic stimulation market include BrainsWay, Nexstim, Magstim, Neuronetics, Salience, MagVenture, Inc., Axilum Robotics, Brainbox Ltd., EB Neuro S.p.A., eNeura Inc., Neurosoft, MAG & More GmbH, Soterix Medical Inc., Magnus Medical, NEUROPREX INC., and others.

5. Which region has the highest share in the transcranial magnetic stimulation (TMS) market?

North America is expected to dominate the overall transcranial magnetic stimulation (TMS) market during the forecast period from 2024-2030. Owing to the factors such as the rising prevalence of neurological disorders, increasing cases of psychiatric disorders, high disposable income, sophisticated healthcare infrastructure, regulatory approval for new products, and high awareness among others, the North America transcranial magnetic stimulation (TMS) market is expected to grow in coming years.

Table of Contents

1.Transcranial Magnetic Stimulation (TMS) Market Report Introduction

2. Transcranial Magnetic Stimulation (TMS) Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Transcranial Magnetic Stimulation (TMS) Market Key Factors Analysis

  • 4.1. Transcranial Magnetic Stimulation (TMS) Market Drivers
    • 4.1.1. Increasing prevalence of neurological disorders
    • 4.1.2. Surge in cases of psychiatric comorbidities such as depression, obsessive-compulsive disorder, and others
    • 4.1.3. Growing preference for non-invasive treatment options
  • 4.2. Transcranial Magnetic Stimulation (TMS) Market Restraints and Challenges
    • 4.2.1. Side effects associated with TMS therapy
    • 4.2.2. Presence of other alternative stimulation therapies
  • 4.3. Transcranial Magnetic Stimulation (TMS) Market Opportunities
    • 4.3.1. Need to develop well-standardized protocols for TMS
    • 4.3.2. Personalization of TMS therapy

5. Transcranial Magnetic Stimulation (TMS) Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Transcranial Magnetic Stimulation (TMS) Market Layout

  • 6.1. By Type
    • 6.1.1. Deep Transcranial Magnetic Stimulator (dTMS)
    • 6.1.2. Repetitive Transcranial Magnetic Stimulator (rTMS)
    • 6.1.3. Others
  • 6.2. By Application
    • 6.2.1. Alzheimer's disease
    • 6.2.2. Obsessive-compulsive disorder (OCD)
    • 6.2.3. Bipolar Depression
    • 6.2.4. Others
  • 6.3. By Age Group
    • 6.3.1. Adults
    • 6.3.2. Children
  • 6.4. By Geography
    • 6.4.1. North America
      • 6.4.1.1. United States Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.1.2. Canada Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.1.3. Mexico Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
    • 6.4.2. Europe
      • 6.4.2.1. France Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.2.2. Germany Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.2.3. United Kingdom Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.2.4. Italy Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.2.5. Spain Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.2.6. Rest of Europe Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
    • 6.4.3. Asia-Pacific
      • 6.4.3.1. China Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.3.2. Japan Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.3.3. India Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.3.4. Australia Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.3.5. South Korea Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.3.6. Rest of Asia-Pacific Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
    • 6.4.4. Rest of the World (RoW)
      • 6.4.4.1. Middle East Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.4.2. Africa Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.4.3. South America Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)

7. Transcranial Magnetic Stimulation (TMS) Market Company and Product Profiles

  • 7.1. BrainsWay
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Nexstim
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Magstim
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Neuronetics
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. Salience
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. MagVenture, Inc.
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. Axilum Robotics
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. Brainbox Ltd.
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. EB Neuro S.p.A.
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. eNeura Inc.
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. Neurosoft
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. MAG & More GmbH
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. Soterix Medical Inc.
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. Magnus Medical
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. NEUROPREX INC.
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Transcranial Magnetic Stimulation (TMS) Market in Global (2021-2030)
  • Table 3: Transcranial Magnetic Stimulation (TMS) Market in Global by Type (2021-2030)
  • Table 4: Transcranial Magnetic Stimulation (TMS) Market in Global by Application (2021-2030)
  • Table 5: Transcranial Magnetic Stimulation (TMS) Market in Global by Age Group (2021-2030)
  • Table 6: Transcranial Magnetic Stimulation (TMS) Market in Global by Geography (2021-2030)
  • Table 7: Transcranial Magnetic Stimulation (TMS) Market in North America (2021-2030)
  • Table 8: Transcranial Magnetic Stimulation (TMS) Market in North America by Country (2021-2030)
  • Table 9: Transcranial Magnetic Stimulation (TMS) Market in the US (2021-2030)
  • Table 10: Transcranial Magnetic Stimulation (TMS) Market in Canada (2021-2030)
  • Table 11: Transcranial Magnetic Stimulation (TMS) Market in Mexico (2021-2030)
  • Table 12: Transcranial Magnetic Stimulation (TMS) Market in Europe (2021-2030)
  • Table 13: Transcranial Magnetic Stimulation (TMS) Market in Europe by Country (2021-2030)
  • Table 14: Transcranial Magnetic Stimulation (TMS) Market in France (2021-2030)
  • Table 15: Transcranial Magnetic Stimulation (TMS) Market in Germany (2021-2030)
  • Table 16: Transcranial Magnetic Stimulation (TMS) Market in the United Kingdom (2021-2030)
  • Table 17: Transcranial Magnetic Stimulation (TMS) Market in Italy (2021-2030)
  • Table 18: Transcranial Magnetic Stimulation (TMS) Market in Spain (2021-2030)
  • Table 19: Transcranial Magnetic Stimulation (TMS) Market in the Rest of Europe (2021-2030)
  • Table 20: Transcranial Magnetic Stimulation (TMS) Market in Asia-Pacific (2021-2030)
  • Table 21: Transcranial Magnetic Stimulation (TMS) Market in Asia-Pacific by Country (2021-2030)
  • Table 22: Transcranial Magnetic Stimulation (TMS) Market in China (2021-2030)
  • Table 23: Transcranial Magnetic Stimulation (TMS) Market in Japan (2021-2030)
  • Table 24: Transcranial Magnetic Stimulation (TMS) Market in India (2021-2030)
  • Table 25: Transcranial Magnetic Stimulation (TMS) Market in Australia (2021-2030)
  • Table 26: Transcranial Magnetic Stimulation (TMS) Market in South Korea (2021-2030)
  • Table 27: Transcranial Magnetic Stimulation (TMS) Market in Rest of Asia-Pacific (2021-2030)
  • Table 28: Transcranial Magnetic Stimulation (TMS) Market in the Rest of the World (2021-2030)
  • Table 29: Transcranial Magnetic Stimulation (TMS) Market in RoW by Region (2021-2030)
  • Table 30: Transcranial Magnetic Stimulation (TMS) Market in the Middle East (2021-2030)
  • Table 31: Transcranial Magnetic Stimulation (TMS) Market in Africa (2021-2030)
  • Table 32: Transcranial Magnetic Stimulation (TMS) Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Transcranial Magnetic Stimulation (TMS) Market in Global (2021-2030)
  • Figure 3: Transcranial Magnetic Stimulation (TMS) Market in Global by Type (2021-2030)
  • Figure 4: Transcranial Magnetic Stimulation (TMS) Market in Global by Application (2021-2030)
  • Figure 5: Transcranial Magnetic Stimulation (TMS) Market in Global by Age Group (2021-2030)
  • Figure 6: Transcranial Magnetic Stimulation (TMS) Market in Global by Geography (2021-2030)
  • Figure 7: Transcranial Magnetic Stimulation (TMS) Market in North America (2021-2030)
  • Figure 8: Transcranial Magnetic Stimulation (TMS) Market in North America by Country (2021-2030)
  • Figure 9: Transcranial Magnetic Stimulation (TMS) Market in the US (2021-2030)
  • Figure 10: Transcranial Magnetic Stimulation (TMS) Market in Canada (2021-2030)
  • Figure 11: Transcranial Magnetic Stimulation (TMS) Market in Mexico (2021-2030)
  • Figure 12: Transcranial Magnetic Stimulation (TMS) Market in Europe (2021-2030)
  • Figure 13: Transcranial Magnetic Stimulation (TMS) Market in Europe by Country (2021-2030)
  • Figure 14: Transcranial Magnetic Stimulation (TMS) Market in France (2021-2030)
  • Figure 15: Transcranial Magnetic Stimulation (TMS) Market in Germany (2021-2030)
  • Figure 16: Transcranial Magnetic Stimulation (TMS) Market in the United Kingdom (2021-2030)
  • Figure 17: Transcranial Magnetic Stimulation (TMS) Market in Italy (2021-2030)
  • Figure 18: Transcranial Magnetic Stimulation (TMS) Market in Spain (2021-2030)
  • Figure 19: Transcranial Magnetic Stimulation (TMS) Market in the Rest of Europe (2021-2030)
  • Figure 20: Transcranial Magnetic Stimulation (TMS) Market in Asia-Pacific (2021-2030)
  • Figure 21: Transcranial Magnetic Stimulation (TMS) Market in Asia-Pacific by Country (2021-2030)
  • Figure 22: Transcranial Magnetic Stimulation (TMS) Market in China (2021-2030)
  • Figure 23: Transcranial Magnetic Stimulation (TMS) Market in Japan (2021-2030)
  • Figure 24: Transcranial Magnetic Stimulation (TMS) Market in India (2021-2030)
  • Figure 25: Transcranial Magnetic Stimulation (TMS) Market in Australia (2021-2030)
  • Figure 26: Transcranial Magnetic Stimulation (TMS) Market in South Korea (2021-2030)
  • Figure 27: Transcranial Magnetic Stimulation (TMS) Market in Rest of Asia-Pacific (2021-2030)
  • Figure 28: Transcranial Magnetic Stimulation (TMS) Market in the Rest of the World (2021-2030)
  • Figure 29: Transcranial Magnetic Stimulation (TMS) Market in RoW by Region (2021-2030)
  • Figure 30: Transcranial Magnetic Stimulation (TMS) Market in the Middle East (2021-2030)
  • Figure 31: Transcranial Magnetic Stimulation (TMS) Market in Africa (2021-2030)
  • Figure 32: Transcranial Magnetic Stimulation (TMS) Market in South America (2021-2030)
  • Figure 33: Market Drivers
  • Figure 34: Market Barriers
  • Figure 35: Marker Opportunities
  • Figure 36: PORTER'S Five Force Analysis